DEBORAH STEVISON: Open Payments
NPI 1740520402 · HAMILTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,468 in 136 payments from 15 companies in 2025. Trend: 2023 $2,477 · 2024 $2,046 · 2025 $2,468
Food & beverage: $2,460Education: $8
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 23 | $388 |
| Axsome Therapeutics, Inc. | 16 | $336 |
| Neurocrine BioSciences, Inc. | 12 | $258 |
| ABBVIE INC. | 21 | $241 |
| Vanda Pharmaceuticals Inc. | 10 | $209 |
| Otsuka America Pharmaceutical, Inc. | 8 | $194 |
| Teva Pharmaceuticals USA, Inc. | 10 | $158 |
| Almatica Pharma LLC | 6 | $154 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $145 |
| Braeburn Inc. | 7 | $110 |
Products named: ARISTADA, Auvelity, INGREZZA, VRAYLAR, HETLIOZ, REXULTI, LOREEV XR, CAPLYTA.
Industry payments across OH — which companies pay providers there.
